Guan X, Stoll B, Lu X, Tappenden KA, Holst JJ, Hartmann B, et al
9 , CD011612 (2015)
Food and Drug Administration states clearly on the Ozempic warning label that semaglutide, the active ingredient, is contraindicated in patients with a personal or family history of MTC or multiple endocrine neoplasia syndrome type 2
Some women say they feel more tired during their first few months on Tirzepatide
Dose Adjustments for Supply and Maintenance Supply disruption: if theres a supply disruption, lowering the dose or lengthening the time between doses may be preferable to ceasing the medication altogether
It might sound complicated but simply put, it means that semaglutide injections have higher rates of success